Stephen Basil Thomas - Director at Climb Bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CLYM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen Basil Thomas since 11/23/2024

Holdings reported by Stephen Basil Thomas for Climb Bio, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 305K $387K $1.27 Aug 7, 2025 Direct
Restricted Stock Units 0 $32.9K $1.31 Jun 27, 2025 Direct Common Stock
Stock Option (Right to Buy) 40K Jun 4, 2025 Direct Common Stock

Transactions reported by Stephen Basil Thomas for Climb Bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.